Related Experiment Video
Updated: Jun 3, 2025
09:04
Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods
Published on: September 10, 2018
9.7K
Contraception Update: A Focus on Safety and Efficacy
Madeline Cohn1, Rachel Novik1, Pelin Batur1,2
1Obstetrics and Gynecology Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Journal of Women'S Health (2002)
|January 8, 2025
Summary
This clinical update reviews recent contraceptive research, focusing on safety and efficacy. It covers updated guidelines for progestin-only pills, estrogen-containing methods in migraineurs, drug interactions, and emergency contraception effectiveness.
Area of Science:
- Reproductive Health
- Pharmacology
- Clinical Medicine
Background:
- Contraceptive research is constantly evolving, necessitating regular updates to clinical practice.
- Understanding the safety and efficacy of various contraceptive methods is crucial for patient care.
- Recent publications offer new insights into hormonal contraception, drug interactions, and emergency contraception.
Purpose of the Study:
- To summarize recent, practice-changing journal articles on contraceptive safety and efficacy.
- To provide an overview of updated medical eligibility recommendations for contraceptive use.
- To highlight key findings regarding progestin-only pills, estrogen-containing contraceptives, and emergency contraception.
Main Methods:
- Review of recently published clinical studies and journal articles.
- Analysis of updated medical eligibility criteria for contraceptive methods.
- Synthesis of evidence on the effectiveness and safety of specific contraceptive formulations and drug interactions.
Main Results:
- Updated recommendations for medical eligibility criteria for contraceptive use.
- Evaluation of the effectiveness of progestin-only pills, including over-the-counter options.
- Assessment of the safety of estrogen-containing contraceptives in individuals with migraine.
- Review of interactions between topiramate and hormonal contraception.
- Examination of nonsteroidal anti-inflammatory drug (NSAID) use with oral emergency contraception to enhance efficacy.
Conclusions:
- Recent research provides critical updates for contraceptive prescribing practices.
- Clinicians should be aware of new guidelines regarding contraceptive safety, efficacy, and drug interactions.
- Evidence supports the use of NSAIDs with oral emergency contraception to improve effectiveness.
Related Concept Videos
01:22Birth Control Methods
187
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
187
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
119
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
119
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
405
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
405
01:19Pharmacovigilance
771
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
771
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
465
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
465
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
707
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
707